View Single Post
Old 23-08-2018, 04:09 PM   #3
st jimmy
Senior Member
Join Date: May 2016
Location: Amsterdam, Netherlands
Posts: 2,299
Likes: 1,499 (899 Posts)

In June 2006, the Food and Drug Administration (FDA) approved the first vaccine against human papillomavirus (HPV), which in less than 1% of all infection causes cervical cancer. Gardasil, of Merck & Co Inc, was licensed for vaccination of females 9 to 26 years.

Merck & Co Inc actively promoted (lobbied) mandatory, school-entry HPV vaccination in several states. Merck proactively contacted legislators to discuss strategies to maximise uptake of Gardasil by introducing legislation, often drafting the bills and searching for a sponsor.
Merck mobilised legislators primarily through Women in Government (WIG), a national, “non-profit group” of female state politicians. Merck contributed unrestricted educational grants to WIG, which covered the expenses of dozens of politicians to go to conferences on cervical cancer at nice destinations and attended by Merck representatives. Merck’s financial contributions to WIG and other interest groups were not publicly disclosed.
Members of WIG introduced many of the mandate bills considered across the country.

In 2007, shortly after Governor Perry of Texas issued an executive order mandating HPV vaccination for girls, a public outcry was sparked after it was reported that the governor’s former chief of staff had worked for years as a lobbyist for Merck and that Merck had contributed $5000 to the governor’s campaign fund.

A respondent from California compared what happened with Gardasil to what earlier happened with Merck’s Fosamax (to prevent osteoporotic fractures):
They created this paranoia about fracture risk and applied it to a much bigger market. I think that they very successfully did the same thing with Gardasil.
Both Merck and GSK, manufacturer of another HPV vaccine, came forward with unrestricted donations for the first time after Gardasil was introduced.
Representatives for Merck were present at task force and committee meetings.
Merck also infiltrated the prescriber community, both directly and by training physicians.

In most states, the politicians preferred to work with the pharmaceutical over their state’s health department.

Mello et al - Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination (2012):
(archived here:

Guess what?
Julie Gerberding, who headed the CDC from 2002 through 2009, after quitting the CDC, became president of the vaccine division at Merck, no doubt for a handsome salary.
Maybe Gerberding's new job - promotion vaccines – isn’t very different from the one she held at the CDC:
Do NOT ever read my posts.
Google and Yahoo wouldn’t block them without a very good reason:
st jimmy is offline   Reply With Quote